Johnson & Johnson names selection committee for Dr. Paul Janssen Award for Biomedical Research

September 12, 2005

NEW BRUNSWICK, N.J., Sept. 12, 2005 -- Johnson & Johnson today announced the appointment of a top-level scientific committee of international experts who will serve as the selection committee to nominate and select the inaugural recipient of the Dr. Paul Janssen Award for Biomedical Research. The Award was created to honor Dr. Paul Janssen, or "Dr. Paul" as he was known throughout the scientific community, one of the 20th century's most gifted and passionate scientists who revolutionized modern medicine and inspired a new generation of researchers. At the time of his death in 2003, Dr. Paul's work had produced more than 80 medicines that helped save millions of lives. In addition, he was the founder of Janssen Pharmaceutica, which later became part of the Johnson & Johnson family of companies.

The Award selection committee, nominated by Dr. Per Peterson, chairman, research & development, pharmaceutical group at Johnson & Johnson, Dr. Harlan Weisman, company group chairman, research & development, pharmaceuticals at Johnson & Johnson, and Dr. Theodore Torphy, corporate vice president, science and technology at Johnson & Johnson, includes:"We are very pleased to establish the Dr. Paul Janssen Award for Biomedical Research in recognition of Dr. Paul's many pioneering contributions to the field of medicine, and to have enlisted such a world-renowned selection committee to identify a scientist who perfectly embodies the tradition of his scientific excellence," said Dr. Peterson. "The Dr. Paul Janssen Award seeks to promote, recognize and reward the same passion and creativity that allowed Dr. Paul to move the boundaries of medical science and to touch the lives of millions of people. We are especially proud of the global composition of the search committee, which represents today's rapidly evolving scientific research community."

The Dr. Paul Janssen Award for Biomedical Research aims to extend the legacy of Dr. Paul by honoring the work of an active scientist in academia, industry or a scientific institute. Given every two years, the Award includes a $100,000 prize and will acknowledge the work of an individual who has made a significant, transformational contribution toward the improvement of human health. According to guidelines agreed to by the selection committee, the recipient of the Award will:The first Award will be presented in September 2006 at the Dr. Paul Janssen Biomedical Research Scientific Symposium and Award Program to be held in Beerse, Belgium, where Janssen Pharmaceutica was first established. The symposium will also commemorate the 80th anniversary of Dr. Paul's birth. In November 2004, to honor Dr. Paul's work in neuroscience, Johnson & Johnson announced a grant of $5 million to Columbia University Medical Center (CUMC) to fund a special scholars program focusing on acceleration of drug discovery and therapeutics for brain-related diseases such as schizophrenia, Alzheimer's disease and epilepsy. The grant established the Paul Janssen Scholars Program in Translational Neuroscience and the partnership between Johnson & Johnson and CUMC builds a valuable bridge to support the work of translational researchers.
About Johnson & Johnson Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, as well as a provider of related services, for the consumer, pharmaceutical, and medical devices and diagnostics markets. The more than 200 Johnson & Johnson operating companies employ approximately 113,800 men and women in 57 countries and sell products throughout the world.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Related Neuroscience Articles from Brightsurf:

Researchers rebuild the bridge between neuroscience and artificial intelligence
In an article in the journal Scientific Reports, researchers reveal that they have successfully rebuilt the bridge between experimental neuroscience and advanced artificial intelligence learning algorithms.

The evolution of neuroscience as a research
When the first issue of the JDR was published, the field of neuroscience did not exist but over subsequent decades neuroscience has emerged as a scientific field that has particular relevance to dentistry.

Diabetes-Alzheimer's link explored at Neuroscience 2019
Surprising links exist between diabetes and Alzheimer's disease, and researchers are beginning to unpack the pathology that connects the two.

Organoid research revealed at Neuroscience 2019
Mini-brains, also called organoids, may offer breakthroughs in clinical research by allowing scientists to study human brain cells without a human subject.

The neuroscience of autism: New clues for how condition begins
UNC School of Medicine scientists found that a gene mutation linked to autism normally works to organize the scaffolding of brain cells called radial progenitors necessary for the orderly formation of the brain.

Harnessing reliability for neuroscience research
Neuroscientists are amassing the large-scale datasets needed to study individual differences and identify biomarkers.

Blue Brain solves a century-old neuroscience problem
In a front-cover paper published in Cerebral Cortex, EPFL's Blue Brain Project, a Swiss Brain Research Initiative, explains how the shapes of neurons can be classified using mathematical methods from the field of algebraic topology.

Characterizing pig hippocampus could improve translational neuroscience
Researchers have taken further steps toward developing a superior animal model of neurological conditions such as traumatic brain injury and epilepsy, according to a study of miniature pigs published in eNeuro.

The neuroscience of human vocal pitch
Among primates, humans are uniquely able to consciously control the pitch of their voices, making it possible to hit high notes in singing or stress a word in a sentence to convey meaning.

Study tackles neuroscience claims to have disproved 'free will'
For several decades, some researchers have argued that neuroscience studies prove human actions are driven by external stimuli -- that the brain is reactive and free will is an illusion.

Read More: Neuroscience News and Neuroscience Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to